| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.06B | +14.9% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥-0.00B | — |
| Gross margin | 23.6% | Net margin -6.6% |
| Revenue Q/Q | -50.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.05B | 76.4% |
| R&D | ¥0.00B | 3.6% |
| SG&A | ¥0.02B | 26.0% |
| Tax & other | ¥-0.00B | -0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
康泰生物 ・ 飞荣达 ・ 立昂技术 ・ 长川科技 ・ 恒锋信息 ・ 金太阳 ・ 拓斯达 ・ 思特奇 ・ 汇纳科技 ・ 晨化股份 ・ 美力科技 ・ 宣亚国际
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies